Do findings from new trials for schizophrenia fit with existing evidence: not duped ... just beguiled?
Clive E Adams, Mahesh Jayaram
Epidemiologia e psichiatria sociale | PENSIERO SCIENTIFICO EDITOR | Published : 2007
No treatment has caused a greater revolution in the treatment of people with schizophrenia than chlorpromazine. The new generation of drugs has been embraced by psychiatry with an enthusiasm fostered by the unmet needs of both patients and industry. Recent, independently funded trials have highlighted already existing data illustrating how the new antipsychotics drugs are an additional advance but not a revolution. In this story there are lessons for psychiatry--to opt for science rather than seduction.